• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    124.63 Down 4.61(3.57%) 4:00PM EDT
    |After Hours : 124.63 0.00 (0.00%) 6:20PM EDT
    Add to Portfolio
    Prev Close:129.24
    Open:126.07
    Bid:124.64 x 200
    Ask:N/A
    1y Target Est:160.35
    Beta:1.09673
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:123.77 - 127.82
    52wk Range:65.91 - 151.75
    Volume:1,305,331
    Avg Vol (3m):1,302,820
    Market Cap:20.08B
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BMRN

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 3.57%20.08B
    FOLDDown 0.70%1.69B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):24.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.20
    Quarterly EPS Est (Sep-15) :-0.64
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-2.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback